Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus

Vaccine

Volumn 31, Issue 50, 2013, Pages 5953-5959

  Liu, Xiaomei ^a   Wei, Shuangshi ^a   Liu, Yan ^a   Fu, Peifen ^a   Gao, Mingchun ^a   Mu, Xiaoyu ^a   Liu, Hua ^a   Xing, Mingwei ^b   Ma, Bo ^a   Wang, JunWei ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Duck enteritis virus (DEV); Goose origin; H5N1 avian influenza virus (AIV); Hemagglutinin (HA)

Indexed keywords

HEMAGGLUTININ; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE DELETION; GENE EXPRESSION; GENETIC STABILITY; GOOSE; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECOMBINANT DUCK ENTERITIS VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; VACCINATION; VIRUS RECOMBINANT; VIRUS STRAIN; WESTERN BLOTTING;

CEF; CHICKEN EMBRYO FIBROBLAST; CPE; CYTOPATHIC EFFECTS; DEF; DEV; DUCK EMBRYO FIBROBLAST; DUCK ENTERITIS VIRUS; DUCK ENTERITIS VIRUS (DEV); GE; GEBN; GEBW; GI; GLYCOPROTEIN E; GLYCOPROTEIN I; GOOSE ORIGIN; H5N1 AVIAN INFLUENZA VIRUS (AIV); HA; HEMAGGLUTININ; HEMAGGLUTININ (HA); HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS; HPAIV; POST-VACCINATION; PV; RDEV; RECOMBINANT DEV; THE EXTRACELLULAR REGION OF GE GENE; THE INTRACELLULAR REGION OF GE GENE; UNIQUE SHORT; US; WILD TYPE DEV; WTDEV;

ANIMALS; ANTIBODIES, VIRAL; CELLS, CULTURED; DRUG CARRIERS; DUCKS; FIBROBLASTS; GENE EXPRESSION PROFILING; GENETIC VECTORS; GENOMIC INSTABILITY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MARDIVIRUS; SERIAL PASSAGE; VACCINES, SYNTHETIC;

EID: 84887609346     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.10.035     Document Type: Article

References (41)

1. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312:404-410.
2. Robinson H.L., Boyle C.A., Feltquate D.M., Morin M.J., Santoro J.C., Webster R.G. DNA immunization for influenza virus: studies using hemagglutinin-and nucleoprotein-expressing DNAs. J Infect Dis 1997, 176. S50-S5.
3. Ducatez M., Webster R., Webby R. Animal influenza epidemiology. Vaccine 2008, 26. D67-D9.
4. Hinshaw V.S., Webster R.G., Turner B. Water-borne transmission of influenza A viruses?. Intervirology 2008, 11. 66-8.
5. Kaleta E., Kuczka A., Kühnhold A., Bunzenthal C., Bönner B., Hanka K., Redmann T., Yilmaz A. Outbreak of duck plague (duck herpesvirus enteritis) in numerous species of captive ducks and geese in temporal conjunction with enforced biosecurity (in-house keeping) due to the threat of avian influenza A virus of the subtype Asia H5N1. DTW Dtsch Tierärztl Wochenschr 2007, 114:3-11.
6. Markwell D.D., Shortridge K.F. Possible waterborne transmission and maintenance of influenza viruses in domestic ducks. Appl Environ Microb 1982, 43. 110-5.
7. Stallknecht D., Shane S., Kearney M., Zwank P. Persistence of avian influenza viruses in water. Avian Dis 1990, 406-11.
8. Keymer I., Gough R. Duck virus enteritis (anatid herpesvirus infection) in mute swans (Cygnus olor). Avian Pathol 1986, 15:161-170.
9. Leibovitz L. Progress report: duck plague surveillance of American anseriformes. J Wildlife Dis 1968, 4:87-91.
10. Wobeser G. Experimental duck plague in blue-winged teal and Canada geese. J Wildlife Dis 1987, 23. 368-75.
11. Janson J. Duck plague. J Am Vet Med Assoc 1968, 152. 1009-16.
12. Lin W., Lam K., Clark W. Isolation of an apathogenic immunogenic strain of duck enteritis virus from waterfowl in California. Avian Dis 1984, 641-650.
13. Lin W., Lam K., Clark W. Active and passive immunization of ducks against duck viral enteritis. Avian Dis 1984, 968-973.
14. Spieker J.O. Virulence assay and other studies of six North American strains of duck plague virus tested in wild and domestic waterfowl 1978, University of Wisconsin, Madison, WI.
15. Liu J., Chen P., Jiang Y., Wu L., Zeng X., Tian G., Ge J., Kawaoka Y., Bu Z., Chen H. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. J Virol 2011, 85:10989-10998.
16. Liu J., Chen P., Jiang Y., Deng G., Shi J., Wu L., Lin Y., Bu Z., Chen H. Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection. Antivir Res 2013, 97:329-333.
17. Morgan R.A., Cornetta K., Anderson W.F. Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. Hum Gene Ther 1990, 1:135-149.
18. Cui H.Y., Wang Y.F., Shi X.M., An T.Q., Tong G.Z., Lan D.S., He L., Liu C.J., Wang M. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens. J Virol Methods 2009, 156:66-72.
19. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microb Rev 1992, 56:152-179.
20. Stallknecht D., Shane S. Host range of avian influenza virus in free-living birds. Vet Res Commun 1988, 12:125-141.
21. Roizman B. Herpesviridae. Fields Virol 1996, 71:2221-2230.
22. Shawky S., Schat K.A. Latency sites and reactivation of duck enteritis virus. Avian Dis 2002, 46:308-313.
23. Zhao Y., Wang J. Characterization of duck enteritis virus US6, US7 and US8 gene. Intervirology 2010, 53:141-145.
24. Zhao Y., Wang J.W., Liu F., Ma B. Molecular analysis of US10 S3, and US2 in duck enteritis virus. Virus Genes 2009, 38:243-248.
25. Balan P., Davis-Poynter N., Bell S., Atkinson H., Browne H., Minson T. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J Gen Virol 1994, 75:1245-1258.
26. Gao H., Cui H., Cui X., Shi X., Zhao Y., Zhao X., Quan Y., Yan S., Zeng W., Wang Y. Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site. PloS one 2011, 6:e22549.
27. Parcells M.S., Anderson A.S., Cantello J.L., Morgan R.W. Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog) US10, and/or US2 and neighboring short-component open reading frames. J Virol 1994, 68:8239-8253.
28. Rebordosa X., Piñol J., Pérez-Pons J.A., Lloberas J., Naval J., Serra-Hartmann X., Espuña E., Querol E., Glycoprotein E of bovine herpesvirus type 1 is involved in virus transmission by direct cell-to-cell spread. Virus Res 1996, 45:59-68.
29. Weber P.C., Levine M., Glorioso J.C. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science 1987, 236:576-579.
30. Mettenleiter T.C., Lomniczi B., Sugg N., Schreurs C., Ben-Porat T. Host cell-specific growth advantage of pseudorabies virus with a deletion in the genome sequences encoding a structural glycoprotein. J Virol 1988, 62:12-19.
31. Cantello J.L., Anderson A., Francesconi A., Morgan R.W. Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene. J Virol 1991, 65:1584-1588.
32. Baigent S.J., Petherbridge L.J., Smith L.P., Zhao Y., Chesters P.M., Nair V.K. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J Gen Virol 2006, 87:769-776.
33. Tsukamoto K., Kojima C., Komori Y., Tanimura N., Mase M., Yamaguchi S. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 1999, 257:352-362.
34. Johnson D., Feenstra V. Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol 1987, 61:2208-2216.
35. Zsak L., Zuckermann F., Sugg N., Ben-Porat T. Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell-to-cell transmission. J Virol 1992, 66:2316-2325.
36. Matsumura T., Kondo T., Sugita S., Damiani A.M., O'Callaghan D.J., Imagawa H. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Virology 1998, 242:68-79.
37. Audonnet J.C., Winslow J., Allen G., Paoletti E. Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE. J Gen Virol 1990, 71:2969-2978.
38. Card J., Whealy M., Robbins A., Enquist L. Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. J Virol 1992, 66:3032-3041.
39. Mettenleiter T.C., Klupp B.G., Weiland F., Visser N. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. J Gen Virol 1994, 75:1723.
40. Sussman M.D., Maes R.K., Kruger J.M., Spatz S.J., Venta P.J. A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis. Virology 1995, 214:12-20.
41. Moormann R.J., de Rover T., Briaire J., Peeters B.P., Gielkens A.L., van Oirschot J.T. Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J Gen Virol 1990, 71:1591-1595.